Conan G. Kinsey
( out of 77 reviews )

Conan G. Kinsey, MD, PhD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Clinic 3A, Gastrointestinal
801-587-4700

  • Specialties

    Board Certification

    American Board of Internal Medicine

    Patient Rating

    4.9 /5
    ( out of 77 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    September 18, 2023
    HUNTSMAN CANCER CENTER

    Dr. Kinsey has been "up front" with me in all aspects since my diagnosis and continuing treatments. He explains everything in "laymen's" terms.

    September 16, 2023
    HUNTSMAN CANCER CENTER

    Dr Kinsey was very good to explain the clinical trials and make his recommendation. Just so happens his recommendation was the trial I had traveled from Charlotte,NC to discuss with him.

    August 14, 2023
    HUNTSMAN CANCER CENTER

    happy with everyone thank one

    August 04, 2023
    HUNTSMAN CANCER CENTER

    Dr Kinsey is fantastic. He explains things in a way that I can understand. He always takes time to answer all questions.

    July 21, 2023
    HUNTSMAN CANCER CENTER

    He is very pleasant, he explained all my tests results and what the next steps were. I had concerns and Dr.Kinsey explained everything.

    June 30, 2023
    HUNTSMAN CANCER CENTER

    I highly recommend Dr Kinsey. He is very caring and patient. He always makes me feel like he cares about me. He listens to me and takes all the time needed to answer my questions in a way that I can understand. He is truly a wonderful doctor.

    June 24, 2023
    HUNTSMAN CANCER CENTER

    Dr. Kinsey is able to communicate with me in a way that helps me alleviate any doubts to our course of action.

    June 23, 2023
    HUNTSMAN CANCER CENTER

    Not only is he an excellent and knowledgeable doctor but that he is willing to go "outside the box" to help me. He is an outstanding doctor.

    June 18, 2023
    HUNTSMAN CANCER CENTER

    always good

    See More Patient Comments

  • Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Oncological Sciences -Adjunct
    Academic Divisions Oncology
    Board Certification
    American Board of Internal Medicine

    Education history

    Postdoctoral Fellowship Hematology/Oncology - Huntsman Cancer Institute Postdoctoral Fellow
    Hematology/Oncology - Huntsman Cancer Institute Fellow
    Residency Internal Medicine - University of Utah School of Medicine Resident
    Genetics and Medicine - University of Rochester School of Medicine and Dentistry M.D., Ph.D.
    Undergraduate Cell Biology/Biochemistry - Bucknell University B.S.

    Selected Publications

    Journal Article

    1. Vaishnavi A, Juan J, Jacob M, Stehn C, Gardner EE, Scherzer MT, Schuman S, Van Veen JE, Murphy B, Hackett CS, Dupuy AJ, Chmura SA, van der Weyden L, Newberg JY, Liu A, Mann K, Rust AG, Weiss WA, Kinsey CG, Adams DJ, Grossmann A, Mann MB, McMahon M (2021). Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis. Cancer Res, 82(22), 4261-4273.
    2. Foth M, Garrido-Laguna I, Kinsey CG (2021). Therapeutic Targeting of Autophagy in Pancreatic Cancer. Surg Oncol Clin N Am, 30(4), 709-718.
    3. Truong A, Yoo JH, Scherzer MT, Sanchez JMS, Dale KJ, Kinsey CG, Richards JR, Shin D, Ghazi PC, Onken MD, Blumer KJ, Odelberg SJ, McMahon M (2020). Chloroquine Sensitizes GNAQ/11-mutated Melanoma to MEK1/2 Inhibition. Clin Cancer Res, 26(23), 6374-6386.
    4. Vaishnavi A, Scherzer MT, Kinsey CG, Parkman GL, Truong A, Ghazi P, Schuman S, Battistone B, Garrido-Laguna I, McMahon M (2019). Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer. Cell Rep, 32(5), 107994.
    5. Kinsey C, Balakrishnan V, ODell MR, Huang JL, Newman L, Whitney-Miller CL, Hezel AF, Land H (2014). Plac8 links oncogenic mutations to regulation of autophagy and is critical to pancreatic cancer progression. Cell Rep, 7(4), 1143-55.
    6. McMurray HR, Sampson ER, Compitello G, Kinsey C, Newman L, Smith B, Chen SR, Klebanov L, Salzman P, Yakovlev A, Land H (2008). Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype. Nature, 453(7198), 1112-6.
    7. Kinsey CG, Bussolati G, Bosco M, Kimura T, Pizzorno MC, Chernin MI, Cassoni P, Novak JF (2007). Constitutive and ligand-induced nuclear localization of oxytocin receptor. J Cell Mol Med, 11(1), 96-110.
    8. Takahashi M, Chernin MI, Yamamoto O, Tonzetich J, Kinsey CG, Novak JF (2002). Transformation of MC3T3-E1 cells following stress and transfection with pSV2neo plasmid. Anticancer Res, 22(2A), 585-98.

    Review

    1. Gajiwala S, Torgeson A, Garrido-Laguna I, Kinsey C, Lloyd S (2018). Combination immunotherapy and radiation therapy strategies for pancreatic cancer-targeting multiple steps in the cancer immunity cycle. [Review]. J Gastrointest Oncol, 9(6), 1014-1026.

    Book Chapter

    1. Gilcrease GW, Kinsey C, Stenehjem D (2015). Environmental and genetic risk factors in hepatocellular carcinoma. In Torre A, Uscanga L (Eds.), Medicina Individualizada De La Evidencia A La Práctica Clínica (pp. 155-62). Permanyer México.

  • Podcasts & News

    News

    Huntsman Cancer Institute News